A research team at the School of Medicine has found that laser treatment designed to destroy the deadly brain cancer glioblastoma can add an average of two months to a patient’s life, compared with chemotherapy. The increase is small but meaningful for people who have only months left to live.
New research from the School of Medicine in St. Louis and the University of California San Diego School of Medicine shows that the Zika virus can kill brain cancer stem cells, the kind of cells most resistant to standard treatments.
New research from the School of Medicine provides clues to why some patients with glioblastoma fare worse and identifies a drug target that potentially could improve survival.
Using a laser probe, neurosurgeons at the Medicine have opened the brain’s protective cover, enabling them to deliver chemotherapy drugs to patients with a form of deadly brain cancer called glioblastoma.
Brain tumor stem cells can resist treatment and regrow tumors, but scientists have identified a vulnerability in these cells that could lead to a new approach in battling deadly brain tumors.
New research at the School of Medicine helps explain why brain tumors occur more often in males and frequently are more harmful than similar tumors in females. Pictured is the study’s senior author, Joshua Rubin, MD, PhD.
Scientists at the School of Medicine have identified a biological marker that may help predict overall survival of people with deadly brain tumors. The marker is made by noncancerous cells known as monocytes (pictured in brown).